DTPa-HBV-IPV/Hib vaccine (GSK217744)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for DTPa-HBV-IPV/Hib vaccine (GSK217744), covering 2014-07-28 to 2014-07-28. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Immunogenicity of a Booster Dose of New Formulations of GlaxoSmithKline Biologicals' DTPa-HBV-IPV/Hib Vaccine (GSK217744) [Phase 2]